Changrun Capital
VC Fund
Shenzhen, China
Changrun Capital is an equity and securities investment and investment consulting firm.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries Changrun Capital invests in
SoftwareManufacturingInformation TechnologyMobileBattery
Stages Changrun Capital invests in
Series ASeries BSeries CPost-IPO EquityVenture - Series Unknown
Countries Changrun Capital invests in
China
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Wei Wang
|
|||
Investment Focus
Industry
- Software 2 (29%)
- Manufacturing 2 (29%)
- Information Technology 2 (29%)
- Mobile 1 (14%)
- Battery 1 (14%)
Stage
- Series A 2 (29%)
- Series B 2 (29%)
- Series C 1 (14%)
- Post-IPO Equity 1 (14%)
- Venture - Series Unknown 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Wei Wang
Founder and Chairman
|
Founder and Chairman | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Yunmai
|
Yunmai is way more than a standard weight scale. Using fitness data technology, lightning fast Bluetooth connectivity, and Body Index analysis capabilities, our body composition scales and mobile app offer actionable insight into your overall health by providing detailed measurements of 10 key body composition measurements.You can easily syncYunmai with a variety of other wellness apps, tools, and technologies such as Apple Health, FitBit, Google Fit, etc. With more data seamlessly streamlined at your fingertips, you can get a better grip on your health. | $31M / Series C / Jun 28, 2021 | |
HappyCast
|
HappyCast develops multi-screen interactive software. Its product can connect smart phone with TV set or projector to display mobile games, live video streaming, video calls and other mobile contents on larger screen. | Series A / Sep 23, 2019 | |
Knowledge Vision
|
Knowledge Vision is an innovative R&D company that specializes in pathological artificial intelligence-assisted analysis and is committed to using artificial intelligence to assist doctors in accurate companion diagnostics. The founder team of Knowledge Vision has more than seven years of experience in innovative medical device developmentrelated to machine learning, familiar with the classification criteria for medical devices, clinical trial specifications, production quality system management, registration processes and fee-related regulations. The company develops a cloud-free platform for research and development of codeless AI applications - AI VIEWER, which utilizes data encryption and authorization mechanisms to ensure user data security and facilitate multi-party cooperation and data sharing. By collecting pathological AI to analyze the commonality of clinical application requirements, standardize and modularize the technologies involved in the research and development of pathological AI, and realize the whole process of data management, image annotation, algorithm development and application release required for pathological AI application research and development. And qualitative, localized, quantitative and visualized, digital analysis of histological pathology. AI VIEWER can be widely used in the pathological analysis of new drug research and development, and is committed to improving the efficiency and quality of drug development CRO. In the process of new drug research and development, AI VIEWER can realize the auxiliary quantitative analysis of digital pathological images, provide visual prediction data for drug researchers, realize traceability, quality assurance and quality control of pathological analysis process, reduce drug development cost and clinical trial risk. To enhance the market competitiveness of drugs. At the same time, the pathological diagnosis results based on quantitative analysis provide intelligent drug-assisted decision-making for new drug researchers, determine the correlation between pathological data characteristics and prognosis, improve the efficiency and progress of quantitative analysis of pathological sections, and ensure the consistency of histopathological analysis. It can be used for screening of subjects and for the determination of concomitant diagnostic cutoff values. | $1.4M / Series A / Jun 14, 2019 | |
Shuwei
|
Shuwei is an indoor positioning services provider for mobile Internet platforms and smartphone manufacturers.Its technology is applied to shopping malls, train stations, office buildings, and restaurants. Shuwei also launched an open precision marketing platform that offers relevant content related to the vehicle, as well as information aboutsimilar cars.The Shenzhen, Guangdon-based company was established in 2014. | Series B / Jul 24, 2018 | |
Sinolion
|
Sinolion provides logistics solutions for subsequent packaging production lines, such as product testing, sorting and conveying, packing boxes, and winding. They serve food and beverages, glass fiber and chemical fiber, chemical coatings, and building materials. The company will continue to be business-driven and driven by technology, steadilypromoting the automation and intelligent development of domestic automated warehousing and logistics. | $7.6M / Post-IPO Equity / Oct 11, 2017 | |
HongTu Separator
|
HongTu Separator manufactures battery separators for specialty applications. The company develops lithium-ion battery separators and common zinc-manganese battery separators with chemical and thermal stability and uniform microporous structure that help automobiles and other industries improve the performance of their electrical equipment.Thecompany was founded in 2005 and is headquartered in Liaoyuan, Jilin. | Venture - Series Unknown / Jun 01, 2017 | |
Hanshow Technology
|
Hanshow Technology Co. Ltd offers connected commerce solutions based on its electronic gondola label (EEG) technology . With an experienced research and development team of 140 employees, the company has installed the most comprehensive EEG systems in the world, covering the entire supply chain. | Series B / Mar 01, 2017 |
Co-Investors
Bright Venture Capital
1 deal together
CAS Investment Management
1 deal together
Charisma Partners
1 deal together
Future Capital Discovery Fund
1 deal together
Guangdong Guoke
1 deal together
Guangzhou Lifeng
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
114,773 investors
Enterprise Investors
90,001 investors
Software Investors
56,294 investors
Climate Investors
43,790 investors
Energy Investors
26,945 investors
Manufacturing Investors
26,762 investors
Mobile Investors
14,171 investors
SaaS VC Funds
70,511 investors
Enterprise VC Funds
57,667 investors
FAQ
What does Changrun Capital invest in?
Changrun Capital invests primarily in Software, Manufacturing and Information Technology startups, most often at Series A and Series B stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Changrun Capital?
Public channels for Changrun Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Changrun Capital?
The team at Changrun Capital includes Wei Wang (Founder and Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
